Potential roles of MNREAD acuity charts and contrast/glare sensitivity in Ranibizumab treatment of branch retinal vein occlusion.

Hirotaka TanabeAkira ObanaSachiko YamamotoKiyomi IchikumiYuko GohtoTakahiko SetoTakanobu Moriyama

Published in: PloS one (2020)

MNREAD and CGS testing were useful for evaluating BRVO treatment efficacy. MRS might be a valuable index for evaluating treatment success and making treatment decisions.

Keyphrases

magnetic resonance
magnetic resonance imaging
diabetic retinopathy
replacement therapy
climate change
smoking cessation
human health
contrast enhanced